← Eichor
Study identifier: NCT07292272 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Halt Aging in Survivors of Blood Cancers

Condition: Hematological Malignancy · Leukemia · Lymphoid Leukemia  ·  Sponsor: University of Nebraska

PhaseNA
Planned participants180
Who can joinAll sexes, 50 Years to no upper limit
Healthy volunteersNo

About this study

Older survivors of blood cancer are at a high risk of accelerated biological aging, which increases their risk of developing multiple aging-related conditions. Whereas physical exercise can improve overall health, older cancer survivors do not meet the recommended physical activity, highlighting the need to develop behavioral interventions to increase adherence. Several other knowledge gaps exist to implement exercise interventions in older survivors of blood cancer; the dose and duration of exercise necessary to slow biological aging in older blood cancer survivors remain unknown. To bridge these gaps in knowledge, we have designed a Phase 2 randomized control trial to test the effects of behavioral and exercise interventions on various outcomes.

This description comes directly from the study's public registry record.

Talk to the study team

Taylor Johnson  ·  402-559-4596  ·  taylora.johnson@unmc.edu

IIT OFFICE  ·  402-559-4596  ·  iitoffice@unmc.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of Nebraska Medical CenterOmaha, Nebraska, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07292272